1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. RIGEL PHARMACEUTICALS
Rigel Pharmaceuticals
XNAS: RIGL

Rigel Pharma Live Stock Price Today, Share Analysis and Chart

Weak Stock
about

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsi...

Read More
26.04 -0.20 (-0.76%)
50.15% Fall from 52W High
299.0K
XNAS Volume

XNAS 08 May, 2026 4:18 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Rigel Pharma is on 14 May 2026 for the purpose of Rigel Pharmaceuticals Inc Annual General Meeting for 2026 See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
12.5 / 100
Momentum Score
Technically Bearish
31.0 / 100
Weak Stock These stocks have poor scores across the board. Investors should be very cautious with these stocks View Similar Embed DVM
Analyst Price Target
51
1Yr Price target upside is 95%
5 analysts

4

S

11

W

5

O

1

T

SWOT Analysis

Rigel Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..